Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.46 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.46 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | F7 | P08709 | 2/20 | 0.45 |
| ▸ | F3 | P13726 | 2/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.45 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2519158 | 0.97 | ALDH1A1 (0.52) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL2518028 | 0.93 | PSMB11 (0.48) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL2517222 | 0.93 | ALDH1A1 (0.55) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL2518096 | 0.92 | ALDH1A1 (0.52) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL2514397 | 0.91 | PSMB11 (0.50) | ALDH1A1CYP3A4ALOX15PTGS2MAPT | |
| SCHEMBL4097267 | 0.91 | PSMB11 (0.50) | ALDH1A1CYP3A4ALOX15PTGS2MAPT | |
| SCHEMBL2513369 | 0.90 | PSMB11 (0.47) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL19873147 | 0.90 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL2518545 | 0.90 | ALDH1A1 (0.54) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL4096611 | 0.90 | MAPT (0.51) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140127146-A1 | Linoleic And Linolenic Acid Esters Of Resveratrol And Cosmetic Compositions | MAES DANIEL H (US) | 2014-05-08 | — | — | US | claimed |
| US-9861564-B2 | Valeric acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT, LLC (US) | 2018-01-09 | — | — | US | disclosed |
| US-9782335-B2 | Malic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2017-10-10 | — | — | US | disclosed |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-10-20 | — | — | US | disclosed |
| EP-2445511-B1 | SKIN REPAIR COMPOSITIONS COMPRISING CIRCADIAN GENE ACTIVATORS AND A SYNERGISTIC COMBINATION OF SIRT1 GENE ACTIVATORS | ELC MAN LLC (US) | 2016-09-07 | — | — | EP | disclosed |
| US-9358194-B2 | Succinic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2016-06-07 | — | — | US | disclosed |
| US-9295621-B2 | Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant | ELC MANAGEMENT LLC (US) | 2016-03-29 | — | — | US | disclosed |
| US-20160038389-A1 | Succinic Acid Esters Of Resveratrol And Cosmetic Compositions | ELC MAN LLC (US) | 2016-02-11 | — | — | US | disclosed |
| US-9180316-B2 | Butyric acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2015-11-10 | — | — | US | disclosed |
| US-9162083-B2 | Linoleic and Linolenic acid esters of resveratrol and cosmetic compositions | ELC MANAGEMENT LLC (US) | 2015-10-20 | — | — | US | disclosed |
| US-8084496-B2 | Resveratrol ferulate compounds and compositions | ELC MANAGEMENT LLC (US) | 2011-12-27 | — | — | US | disclosed |
| US-20110250251-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | MAES DANIEL H | 2011-10-13 | — | — | US | disclosed |
| US-20100216879-A1 | Resveratrol Ferulate Compounds And Compositions | MAES DANIEL H | 2010-08-26 | — | — | US | disclosed |
| US-20100080845-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | MAES DANIEL H | 2010-04-01 | — | — | US | disclosed |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | ELC MANAGEMENT LLC | 2009-02-19 | — | — | US | disclosed |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | ELC MANAGEMENT LLC | 2009-02-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (12 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090035243-A1 | Anhydrous Cosmetic Compositions Containing Resveratrol Derivatives | RB1, SIRT1, EP300 | ALDH1A1 608/4885CYP3A4 3306/4885ALOX15 2910/4885 |
| US-20090035242-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Linear Or Branched Silicone | SQLE, SMURF1, PIK3R1 | ALDH1A1 3102/4885CYP3A4 3607/4885ALOX15 445/4885 |
| US-20100216879-A1 | Resveratrol Ferulate Compounds And Compositions | FER, FOLR1, FOLR2 | ALDH1A1 1726/4885CYP3A4 386/4885ALOX15 2713/4885 |
| US-20090047309-A1 | COSMETIC METHODS AND COMPOSITIONS FOR REPAIRING HUMAN SKIN | CUTA, ERCC1, OGG1 | ALDH1A1 527/4885CYP3A4 1901/4885ALOX15 867/4885 |
| US-20110250251-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | CUTA, ERCC1, OGG1 | ALDH1A1 527/4885CYP3A4 1901/4885ALOX15 867/4885 |
| US-20160303016-A1 | Valeric Acid Esters Of Resveratrol And Cosmetic Compositions | CUTA, SUV39H1, RARA | ALDH1A1 717/4885CYP3A4 272/4885ALOX15 498/4885 |
| US-20090035237-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant | SMURF1, CUTA, SMURF2 | ALDH1A1 3004/4885CYP3A4 3939/4885ALOX15 1416/4885 |
| US-20090035236-A1 | Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent | CUTA, LRAT, RARA | ALDH1A1 2717/4885CYP3A4 3477/4885ALOX15 151/4885 |
| US-20090035240-A1 | Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent | SMARCC1, RARG, RARA | ALDH1A1 2613/4885CYP3A4 3430/4885ALOX15 1327/4885 |
| US-20100080845-A1 | Cosmetic Methods And Compositions For Repairing Human Skin | CUTA, ERCC1, OGG1 | ALDH1A1 527/4885CYP3A4 1901/4885ALOX15 867/4885 |
| US-20160038389-A1 | Succinic Acid Esters Of Resveratrol And Cosmetic Compositions | SUCNR1, SIRT1, SUCLA2 | ALDH1A1 588/4885CYP3A4 1000/4885ALOX15 1491/4885 |
| US-20140127146-A1 | Linoleic And Linolenic Acid Esters Of Resveratrol And Cosmetic Compositions | LRAT, ELOVL1, ELOVL6 | ALDH1A1 529/4885CYP3A4 3020/4885ALOX15 6/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.